Precision Medicine in Rare Hematological Diseases: Pyruvate Kinase Activators
Join us on this podcast episode featuring Prof Lucia de Franceschi (Department of Medicine, University of Verona, Italy) as she discusses the latest advances on the use of Pyruvate kinase activators in the treatment of rare hematological diseases.
Learn about the crucial role of Pyruvate kinase (PK) in erythrocyte metabolism and how pyruvate kinase activators are emerging as a new therapeutic option for chronic hemolytic anemias that had previously no other treatment than transfusion or iron chelation.
Discover how two oral pyruvate kinase activators, Mitapivat and Etavopivat, can help…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.